BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Rosaria Spinella, Rohit Sawhney, Rajiv Jalan. Albumin in chronic liver disease: structure, functions and therapeutic implicationsHepatology International 2016; 10(1): 124 doi: 10.1007/s12072-015-9665-6
2
Aziza Ajlan, Waleed K. Al-hamoudi, Hussein Elsiesy. Ascites - Physiopathology, Treatment, Complications and Prognosis2017;  doi: 10.5772/intechopen.70544
3
Marco Di Pascoli, Silvano Fasolato, Salvatore Piano, Massimo Bolognesi, Paolo Angeli. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascitesLiver International 2019; 39(1): 98 doi: 10.1111/liv.13968
4
Danielle Adebayo, Shuet Fong Neong, Florence Wong. Ascites and Hepatorenal SyndromeClinics in Liver Disease 2019; 23(4): 659 doi: 10.1016/j.cld.2019.06.002
5
Young Seok Kim. Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis in Patients with Portal HypertensionThe Korean Journal of Gastroenterology 2010; 56(3): 168 doi: 10.4166/kjg.2010.56.3.168
6
Rafael Bañares, Mauro Bernardi. Long-term albumin administration in patients with decompensated cirrhosis. It is time for a reappraisalLiver International 2019; 39(1): 45 doi: 10.1111/liv.13996
7
Satoshi Yasumura, Masanori Matsumoto, Shigeyoshi Makino, Shuichi Kino, Asashi Tanaka, Takehiro Kohno, Akito Nozaki, Koji Matsuzaki, Yuji Yonemura, Tadashi Matsushita. EVIDENCE-BASED GUIDELINES FOR THE USE OF ALBUMIN PRODUCTS (SECOND EDITION)Japanese Journal of Transfusion and Cell Therapy 2018; 64(6): 700 doi: 10.3925/jjtc.64.700
8
Patricia Huelin, Jose Ignacio Fortea, Javier Crespo, Emilio Fábrega. Ascites - Physiopathology, Treatment, Complications and Prognosis2017;  doi: 10.5772/intechopen.70384
9
Zhen Chen, Yang He, Bo Shi, Daichang Yang. Human serum albumin from recombinant DNA technology: Challenges and strategiesBiochimica et Biophysica Acta (BBA) - General Subjects 2013; 1830(12): 5515 doi: 10.1016/j.bbagen.2013.04.037
10
Paolo Caraceni, Oliviero Riggio, Paolo Angeli, Carlo Alessandria, Sergio Neri, Francesco G Foschi, Fabio Levantesi, Aldo Airoldi, Sergio Boccia, Gianluca Svegliati-Baroni, Stefano Fagiuoli, Roberto G Romanelli, Raffaele Cozzolongo, Vito Di Marco, Vincenzo Sangiovanni, Filomena Morisco, Pierluigi Toniutto, Annalisa Tortora, Rosanna De Marco, Mario Angelico, Irene Cacciola, Gianfranco Elia, Alessandro Federico, Sara Massironi, Riccardo Guarisco, Alessandra Galioto, Giorgio Ballardini, Maria Rendina, Silvia Nardelli, Salvatore Piano, Chiara Elia, Loredana Prestianni, Federica Mirici Cappa, Lucia Cesarini, Loredana Simone, Chiara Pasquale, Marta Cavallin, Alida Andrealli, Federica Fidone, Matteo Ruggeri, Andrea Roncadori, Maurizio Baldassarre, Manuel Tufoni, Giacomo Zaccherini, Mauro Bernardi, Marco Domenicali, Ferdinando A Giannone, Manuela Merli, Stefania Gioia, Silvano Fasolato, Antonietta Sticca, Daniela Campion, Alessandro Risso, Giorgio M Saracco, Daniela Maiorca, Agostino Rizzotto, Arianna Lanzi, Elga Neri, Anna Visani, Antonio Mastroianni, Alberto B Alberti, Chiara Mazzarelli, Marcello Vangeli, Marco Marzioni, Francesca Capretti, Alba Kostandini, Giulia Magini, Maria Colpani, Giacomo Laffi, Tommaso Gabbani, Maria Marsico, Marianna Zappimbulso, Josè Petruzzi, Vincenza Calvaruso, Giovanni Parrella, Nicola Caporaso, Francesco Auriemma, Maria Guarino, Fabio Pugliese, Antonio Gasbarrini, Pietro Leo, Francesco De Leonardis, Alessandra Pecchioli, Piera Rossi, Giovanni Raimondo, Elisa Negri, Marcello Dallio, Carmelina Loguercio, Dario Conte, Natascia Celli, Roberto Bringiotti, Nicola M Castellaneta, Francesco Salerno. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trialThe Lancet 2018; 391(10138): 2417 doi: 10.1016/S0140-6736(18)30840-7
11
Florence Wong. Management of ascites in cirrhosisJournal of Gastroenterology and Hepatology 2012; 27(1): 11 doi: 10.1111/j.1440-1746.2011.06925.x
12
Qi-Ci Wu, Dong-Qiang Lin, Wei Shi, Qi-Lei Zhang, Shan-Jing Yao. A mixed-mode resin with tryptamine ligand for human serum albumin separationJournal of Chromatography A 2016; 1431: 145 doi: 10.1016/j.chroma.2015.12.066
13
Bahaa Eldeen Senousy, Peter V Draganov. Evaluation and management of patients with refractory ascitesWorld Journal of Gastroenterology 2009; 15(1): 67-80 doi: 10.3748/wjg.15.67
14
Rita Garcia-Martinez, Paolo Caraceni, Mauro Bernardi, Pere Gines, Vicente Arroyo, Rajiv Jalan. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complicationsHepatology 2013; 58(5): 1836 doi: 10.1002/hep.26338
15
Wen-Ning Chu, Qi-Ci Wu, Qi-Lei Zhang, Shan-Jing Yao, Dong-Qiang Lin. High-Throughput Process Development for Recombinant Human Serum Albumin Separation from Pichia pastoris Broth with Mixed-Mode ChromatographyIndustrial & Engineering Chemistry Research 2019; 58(8): 3238 doi: 10.1021/acs.iecr.8b04596
16
Bruce A. Runyon. Sleisenger and Fordtran's Gastrointestinal and Liver Disease2010; : 1517 doi: 10.1016/B978-1-4160-6189-2.00091-3
17
Paolo Caraceni, Paolo Angeli, Daniele Prati, Mauro Bernardi, Carlo Alessandria, Oliviero Riggio, Francesco Salerno, Giancarlo Maria Liumbruno, Francesco Bennardello, Pierluigi Piccoli, Claudio Velati, Pierluigi Berti, Giuseppina Facco, Francesco Fiorin. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosisDigestive and Liver Disease 2016; 48(1): 4 doi: 10.1016/j.dld.2015.11.008
18
P.F.W. Strengers, E. van Twuijver. Side Effects of Drugs Annual 2009; 31: 527 doi: 10.1016/S0378-6080(09)03133-X
19
Elsa Solà, Cristina Solé, Macarena Simón-Talero, Marta Martín-Llahí, José Castellote, Rita Garcia-Martínez, Rebeca Moreira, Maria Torrens, Francisca Márquez, Núria Fabrellas, Gloria de Prada, Patrícia Huelin, Eva Lopez Benaiges, Meritxell Ventura, Marcela Manríquez, André Nazar, Xavier Ariza, Pilar Suñé, Isabel Graupera, Elisa Pose, Jordi Colmenero, Marco Pavesi, Mónica Guevara, Miquel Navasa, Xavier Xiol, Joan Córdoba, Victor Vargas, Pere Ginès. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trialJournal of Hepatology 2018; 69(6): 1250 doi: 10.1016/j.jhep.2018.08.006
20
Joana R. Carvalho, Mariana Verdelho Machado. New Insights About Albumin and Liver DiseaseAnnals of Hepatology 2018; 17(4): 547 doi: 10.5604/01.3001.0012.0916
21
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications Clinical and Molecular Hepatology 2018; 24(3): 230 doi: 10.3350/cmh.2018.1005
22
Christian J. Wiedermann. Reducing Mortality in Acute Kidney Injury2016; : 133 doi: 10.1007/978-3-319-33429-5_16
23
Fredric D. Gordon. AscitesClinics in Liver Disease 2012; 16(2): 285 doi: 10.1016/j.cld.2012.03.004
24
Mauro Bernardi, Paolo Angeli, Joan Claria, Richard Moreau, Pere Gines, Rajiv Jalan, Paolo Caraceni, Javier Fernandez, Alexander L Gerbes, Alastair J O'Brien, Jonel Trebicka, Thierry Thevenot, Vicente Arroyo. Albumin in decompensated cirrhosis: new concepts and perspectivesGut 2020; 69(6): 1127 doi: 10.1136/gutjnl-2019-318843
25
Shuet Fong Neong, Danielle Adebayo, Florence Wong. An update on the pathogenesis and clinical management of cirrhosis with refractory ascitesExpert Review of Gastroenterology & Hepatology 2019; 13(4): 293 doi: 10.1080/17474124.2018.1555469
26
Mauro Bernardi, Paolo Caraceni, Roberta J. Navickis, Mahlon M. Wilkes. Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trialsHepatology 2012; 55(4): 1172 doi: 10.1002/hep.24786
27
Wesley Leung, Florence Wong. Medical management of ascitesExpert Opinion on Pharmacotherapy 2011; 12(8): 1269 doi: 10.1517/14656566.2011.549126
28
Koichi Kozaki, Masahiro IInuma, Tomoyuki Takagi, Takanori Fukuda, Takaya Sanpei, Yusuke Terunuma, Yoshiharu Yatabe, Kazuhiro Akano. Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver CirrhosisTherapeutic Apheresis and Dialysis 2016; 20(4): 376 doi: 10.1111/1744-9987.12469
29
Elsa Solà, Cristina Solé, Pere Ginès, Kathleen E. Corey, Harmeet Malhi. New Strategies for the Management of Decompensated Cirrosis: Long‐Term Albumin Administration for Everyone?Hepatology 2019; 69(5): 2289 doi: 10.1002/hep.30357
30
Macarena Simón-Talero, Rita García-Martínez, Maria Torrens, Salvador Augustin, Susana Gómez, Gustavo Pereira, Mónica Guevara, Pere Ginés, Germán Soriano, Eva Román, Jordi Sánchez-Delgado, Roser Ferrer, Juan C. Nieto, Pilar Sunyé, Inma Fuentes, Rafael Esteban, Juan Córdoba. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind studyJournal of Hepatology 2013; 59(6): 1184 doi: 10.1016/j.jhep.2013.07.020
31
Adam J. Schiro. Liver Disorders2017; : 507 doi: 10.1007/978-3-319-30103-7_30
32
Alastair J O'Brien, James N Fullerton, Karen A Massey, Grace Auld, Gavin Sewell, Sarah James, Justine Newson, Effie Karra, Alison Winstanley, William Alazawi, Rita Garcia-Martinez, Joan Cordoba, Anna Nicolaou, Derek W Gilroy. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2Nature Medicine 2014; 20(5): 518 doi: 10.1038/nm.3516
33
Tyree H Kiser, Robert MacLaren, Douglas N Fish. Treatment of Hepatorenal SyndromePharmacotherapy 2009; 29(10): 1196 doi: 10.1592/phco.29.10.1196
34
Paolo Caraceni, Marco Domenicali, Alessandra Tovoli, Lucia Napoli, Carmen Serena Ricci, Manuel Tufoni, Mauro Bernardi. Clinical indications for the albumin use: Still a controversial issueEuropean Journal of Internal Medicine 2013; 24(8): 721 doi: 10.1016/j.ejim.2013.05.015
35
Gennaro D'Amico, Alberto Morabito, Mario D'Amico, Linda Pasta, Giuseppe Malizia, Paola Rebora, Maria Grazia Valsecchi. Clinical states of cirrhosis and competing risksJournal of Hepatology 2018; 68(3): 563 doi: 10.1016/j.jhep.2017.10.020
36
Mauro Bernardi, Giacomo Zaccherini, Paolo Caraceni. Pro: The Role of Albumin in Pre–Liver Transplant ManagementLiver Transplantation 2019; 25(1): 128 doi: 10.1002/lt.25356
37
Bianca Boff Sandi, Gabriel Stefani Leão, Angelo Alves Mattos, Ângelo Zambam Mattos. Long‐term albumin administration in patients with cirrhosis and ascites: A meta‐analysis of randomized controlled trialsJournal of Gastroenterology and Hepatology 2020;  doi: 10.1111/jgh.15253
38
Mauro Bernardi, Carmen S. Ricci, Giacomo Zaccherini. Role of Human Albumin in the Management of Complications of Liver CirrhosisJournal of Clinical and Experimental Hepatology 2014; 4(4): 302 doi: 10.1016/j.jceh.2014.08.007
39
Guadalupe Garcia-Tsao. Long-term albumin in cirrhosis: is it the ANSWER?The Lancet 2018; 391(10138): 2391 doi: 10.1016/S0140-6736(18)30948-6
40
F. Wong. Liver Cirrhosis: From Pathophysiology to Disease Management2008; 162: 248 doi: 10.1007/978-1-4020-8656-4_23
41
Shashideep Singhal, Kiran K. Baikati, Ibrahim I. Jabbour, Sury Anand. Management of Refractory AscitesAmerican Journal of Therapeutics 2012; 19(2): 121 doi: 10.1097/MJT.0b013e3181ff7a8b
42
Kazuhisa Uchiyama, Kazunari Mori, Katsuyoshi Tabuse, Masaki Ueno, Satoru Ozawa, Takayuki Nakase, Manabu Kawai, Masaji Tani, Hiroshi Tanimura, Hiroki Yamaue. Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic functionJournal of Hepato-Biliary-Pancreatic Surgery 2008; 15(6): 596 doi: 10.1007/s00534-007-1326-2
43
Rosa G Simonetti, Giovanni Perricone, Dimitrinka Nikolova, Goran Bjelakovic, Christian Gluud. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesisCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD004039.pub2
44
J. Boldt. Querschnittleitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten: HumanalbuminDer Anaesthesist 2010; 59(6): 566 doi: 10.1007/s00101-010-1734-6
45
Isao Sakaida. Tolvaptan for the treatment of liver cirrhosis oedemaExpert Review of Gastroenterology & Hepatology 2014; 8(5): 461 doi: 10.1586/17474124.2014.903797
46
Jürgen Schölmerich. Medizinische Therapie 2007 | 20082007; : 941 doi: 10.1007/978-3-540-48554-4_81
47
A.B. Johan Groeneveld, Roberta J. Navickis, Mahlon M. Wilkes. Update on the Comparative Safety of ColloidsAnnals of Surgery 2011; 253(3): 470 doi: 10.1097/SLA.0b013e318202ff00
48
Florence Wong. The Critically Ill Cirrhotic Patient2020; : 11 doi: 10.1007/978-3-030-24490-3_2
49
Bruce A. Runyon. Management of adult patients with ascites due to cirrhosis: An updateHepatology 2009; 49(6): 2087 doi: 10.1002/hep.22853
50
Elsa Solà, Pere Ginès. Renal and circulatory dysfunction in cirrhosis: Current management and future perspectivesJournal of Hepatology 2010; 53(6): 1135 doi: 10.1016/j.jhep.2010.08.001
51
Wesley Leung, Florence Wong. Hepatorenal Syndrome: Do the Vasoconstrictors Work?Gastroenterology Clinics of North America 2011; 40(3): 581 doi: 10.1016/j.gtc.2011.06.011
52
Paolo Caraceni, Marco Pavesi, Maurizio Baldassarre, Mauro Bernardi, Vicente Arroyo. The use of human albumin in patients with cirrhosis: a European surveyExpert Review of Gastroenterology & Hepatology 2018; 12(6): 625 doi: 10.1080/17474124.2018.1460203
53
Marta Martín–Llahí, Marie–Noëlle Pépin, Mónica Guevara, Fernando Díaz, Aldo Torre, Alberto Monescillo, Germán Soriano, Carlos Terra, Emilio Fábrega, Vicente Arroyo, Juan Rodés, Pere Ginès. Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized StudyGastroenterology 2008; 134(5): 1352 doi: 10.1053/j.gastro.2008.02.024
54
Ya-wu Zhang, Feng-xian Wei, Zhen-gang Wei, Gen-nian Wang, Man-cai Wang, You-cheng Zhang. Elective Splenectomy Combined with Modified Hassab’s or Sugiura Procedure for Portal Hypertension in Decompensated CirrhosisCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/1208614
55
Mauro Bernardi, Caterina Maggioli, Giacomo Zaccherini. Human albumin in the management of complications of liver cirrhosisCritical Care 2012; 16(2) doi: 10.1186/cc11218
56
J. Boldt. RETRACTED: Use of albumin: an updateBritish Journal of Anaesthesia 2010; 104(3): 276 doi: 10.1093/bja/aep393
57
Y. He, T. Ning, T. Xie, Q. Qiu, L. Zhang, Y. Sun, D. Jiang, K. Fu, F. Yin, W. Zhang, L. Shen, H. Wang, J. Li, Q. Lin, Y. Sun, H. Li, Y. Zhu, D. Yang. Large-scale production of functional human serum albumin from transgenic rice seedsProceedings of the National Academy of Sciences 2011; 108(47): 19078 doi: 10.1073/pnas.1109736108
58
Francesco Salerno, Massimo Cazzaniga, Silvia Accordino. May vaptans contribute to the treatment of refractory ascites?Journal of Hepatology 2010; 53(2): 225 doi: 10.1016/j.jhep.2010.04.003
59
M. Bernardi, C. Maggioli, G. Zaccherini. Annual Update in Intensive Care and Emergency Medicine 20122012; : 421 doi: 10.1007/978-3-642-25716-2_39
60
Nikhilesh R. Mazumder, Kofi Atiemo, Matthew Kappus, Giuseppe Cullaro, Matthew E. Harinstein, Daniela Ladner, Elizabeth Verna, Jennifer Lai, Josh Levitsky. A Comprehensive Review of Outcome Predictors in Low MELD PatientsTransplantation 2020; 104(2): 242 doi: 10.1097/TP.0000000000002956
61
Hengo Haljamäe. Alternatives to Blood Transfusion in Transfusion Medicine2010; : 119 doi: 10.1002/9781444319583.ch10
62
Satoshi Yasumura, Shigeyoshi Makino, Masanori Matsumoto, Takehiro Kono, Shuichi Kino, Asashi Tanaka, Akemi Wakisaka, Yuji Yonemura, Tadashi Matsushita. Evidence-based Guidelines for the Use of Albumin Products Japan Society of Transfusion Medicine and Cell TherapyJapanese Journal of Transfusion and Cell Therapy 2017; 63(5): 641 doi: 10.3925/jjtc.63.641
63
Kurt Lenz, Robert Buder, Lisbeth Kapun, Martin Voglmayr. Treatment and management of ascites and hepatorenal syndrome: an updateTherapeutic Advances in Gastroenterology 2015; 8(2): 83 doi: 10.1177/1756283X14564673
64
Saqib Walayat, Daniel Martin, Jaymon Patel, Umair Ahmed, Muhammad N. Asghar, Aparna U. Pai, Sonu Dhillon. Role of albumin in cirrhosis: from a hospitalist’s perspectiveJournal of Community Hospital Internal Medicine Perspectives 2017; 7(1): 8 doi: 10.1080/20009666.2017.1302704
65
Yoshihiro Onishi, Takafumi Wakita, Shinichi Fukuhara, Yoshinori Noguchi, Mitsuru Okada, Isao Sakaida, Yutaka Sasaki, Kenji Kobayashi. Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7Clinical and Translational Gastroenterology 2014; 5(2): e48 doi: 10.1038/ctg.2013.20
66
Amine Benmassaoud, Suzanne C Freeman, Davide Roccarina, Maria Corina Plaz Torres, Alex J Sutton, Nicola J Cooper, Laura Iogna Prat, Maxine Cowlin, Elisabeth Jane Milne, Neil Hawkins, Brian R Davidson, Chavdar S Pavlov, Douglas Thorburn, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysisCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013123.pub2
67
Meyler's Side Effects of Drugs2016; : 111 doi: 10.1016/B978-0-444-53717-1.00236-5
68
Mauro Bernardi, Paolo Caraceni. Novel perspectives in the management of decompensated cirrhosisNature Reviews Gastroenterology & Hepatology 2018; 15(12): 753 doi: 10.1038/s41575-018-0045-2